10-K/A: Archer-Daniels-Midland Restates Financials After Internal Review Reveals Accounting Errors

Sentiment:

Annual Results Amendment


Archer-Daniels-Midland Company is restating its financial statements for the past three years due to misclassified intersegment sales and a material weakness in internal controls.

Delay expectedThe filing of the amended annual report (Form 10-K/A) indicates a delay in the release of accurate financial information.
Worse than expectedThe document contains worse than expected results due to the restatement of financial statements and the identification of a material weakness in internal control over financial reporting.

Summary

  • Archer-Daniels-Midland Company (ADM) is filing an amendment to its annual report to restate its financial statements for the years ended December 31, 2023, 2022, and 2021.
  • The restatement is due to errors in segment-specific historical financial information, specifically related to intersegment sales.
  • These errors do not impact ADM's consolidated statements of earnings, comprehensive income, balance sheets, cash flows, or shareholders' equity.
  • The company identified a material weakness in its internal control over financial reporting related to accounting practices for intersegment sales.
  • The errors were discovered following dialogue with the SEC and an internal investigation.
  • The company is also restating its quarterly reports for the first and second quarters of 2024.
  • The restatement includes corrections for misclassified intersegment transactions and segment disclosure presentation errors.
  • The company is cooperating with the SEC and the Department of Justice (DOJ) regarding these issues.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the restatement of financials, identification of a material weakness, and ongoing government investigations. While the company is taking steps to remediate the issues, the overall tone is concerning from an investment perspective.

Positives

  • The company is taking steps to remediate the material weakness in internal controls.
  • ADM is cooperating with the SEC and DOJ investigations.
  • The restatements do not impact the consolidated financial statements.

Negatives

  • A material weakness in internal control over financial reporting was identified.
  • The company is restating its financial statements for multiple years.
  • The company is under investigation by the SEC and DOJ.
  • The company has identified additional misclassified intersegment transactions during the remediation process.

Risks

  • The company faces risks related to the ongoing government investigations, which could result in fines, penalties, or other sanctions.
  • The material weakness in internal control could lead to additional accounting errors or impact the accuracy and timeliness of future reports.
  • Negative publicity from the investigation could adversely affect the company's reputation and stock price.
  • The company's credit ratings have been placed on watch, which could affect its access to credit markets.
  • The company may face securities litigation and other claims arising from the investigation.

Future Outlook

The company anticipates spending between $360 million and $490 million on capital projects to achieve its Strive 35 targets. The company expects capital expenditures of $1.3 billion and additional cash outlays of approximately $1.0 billion in dividends and up to $2.3 billion in share repurchases in 2024.

Management Comments

  • ADM's strategic plan of sustainable growth leverages the trends and technologies in sustainability to help the Company grow and create value for its stakeholders.
  • The Company aims to mitigate climate change and protect biodiversity through renewable product and process innovations, supply chain efforts including a commitment to no-deforestation or native vegetation conversion and regenerative agriculture, and a strategic approach to operational excellence with a focus on enhancing the efficiency of ADM's production plants throughout its global operations.

Industry Context

The restatement and internal control issues highlight the complexities of managing a large, global agricultural supply chain and processing business. The company's focus on sustainability and innovation is aligned with broader industry trends, but the accounting issues raise concerns about internal controls and risk management.

Comparison to Industry Standards

  • The restatement of financial statements due to intersegment sales issues is not a common occurrence among large, publicly traded companies, suggesting a potential deficiency in ADM's internal controls compared to industry best practices.
  • Other large agricultural companies such as Bunge and Cargill have not reported similar issues with intersegment sales, indicating that ADM's situation may be unique.
  • The material weakness in internal control over financial reporting is a significant concern, as it suggests a lack of adequate oversight and processes compared to industry standards for financial reporting.
  • The ongoing investigations by the SEC and DOJ are also unusual for companies of ADM's size and stature, indicating a potential deviation from industry norms in terms of compliance and risk management.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerVikram LutharMonish PatolawalaAugust 2024Vikram Luthar was placed on administrative leave effective January 19, 2024 and his employment was terminated September 30, 2024.
Interim Chief Financial OfficernaIsmael RoigJanuary 2024Vikram Luthar was placed on administrative leave effective January 19, 2024.
Chief Risk OfficerGary McGuiganJon TurneyJanuary 2024Gary McGuigan became President, Asia Pacific.
President, Asia PacificJoseph D. TaetsGary McGuiganDecember 2023Joseph D. Taets became Senior Vice President, Nutrition Operations.
Senior Vice President, Nutrition OperationsnaJoseph D. TaetsDecember 2023Joseph D. Taets was previously President, Asia Pacific.
President, Animal NutritionIsmael RoigJoseph D. TaetsFebruary 2024Ismael Roig became Interim Chief Financial Officer.
President, NutritionIan PinnerIan PinnerNovember 2023Ian Pinner also became Chief Sales and Marketing Officer.
President, Precision Fermentation and ADM VenturesnaLeticia GoncalvesNovember 2023Leticia Goncalves was previously President, Global Foods.
Senior Vice President, Global OperationsnaDermot O'GradyNovember 2023Dermot O'Grady was previously Vice President, Oilseeds Operations EMEA.
Senior Vice President, General Counsel and SecretarynaRegina Bynote JonesSeptember 2023Regina Bynote Jones was previously Chief Legal Officer at Baker Hughes.
Senior Vice President and Chief Science OfficernaNuria MiguelAugust 2023Nuria Miguel was previously Vice President, Human and Animal Nutrition.
Vice President and Corporate TreasurernaRodolfo LutermanDecember 2023Rodolfo Luterman was previously Assistant Treasurer.
Vice President and Chief Integrity OfficernaBenjamin I. BardDecember 2023Benjamin I. Bard was previously Global Chief Compliance Officer.

Legal Proceedings

  • The company is involved in several legal actions, including class action lawsuits related to commodity trading.
  • The company is cooperating with the SEC and DOJ investigations related to intersegment sales.

Stakeholder Impact

  • Shareholders are impacted by the restatement of financial statements and the decline in stock price.
  • Employees may be affected by the internal control issues and potential restructuring.
  • Customers and suppliers may be impacted by the negative publicity and potential changes in business practices.
  • Creditors may be concerned about the company's credit ratings and access to credit markets.

Next Steps

  • The company will continue to cooperate with the SEC and DOJ investigations.
  • The company will implement enhancements to its internal controls to remediate the identified material weakness.
  • The company will test the design and operational effectiveness of the new and enhanced controls.
  • The company will monitor potential and enacted tax changes, including the implementation of Pillar Two legislation, in the countries in which the Company operates.

Key Dates

DateDescription
January 21, 2024ADM announced the internal investigation and placed the CFO on administrative leave.
March 12, 2024Original Form 10-K for fiscal year 2023 was filed with the SEC.
April 10, 2024Definitive proxy statement for the 2024 annual meeting of stockholders was filed.
April 30, 2024Original Form 10-Q for the quarter ended March 31, 2024 was filed with the SEC.
July 30, 2024Original Form 10-Q for the quarter ended June 30, 2024 was filed with the SEC.
November 18, 2024Amended Form 10-K/A for fiscal year 2023 was filed with the SEC.

Keywords

restatement, intersegment sales, material weakness, internal control, SEC investigation, DOJ investigation, financial reporting, segment reporting, accounting errors, financial statements

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.